Antibiotics cause yeast infections by killing the protective bacteria that normally keep yeast in check. About 22% of women develop a symptomatic yeast infection within four to six weeks of taking a short course of oral antibiotics, according to a study in the Journal of the American Board of Family Medicine. The connection comes down to a disrupted balance: your body already has yeast living in it, and antibiotics remove the bacteria that prevent that yeast from growing out of control.
How Protective Bacteria Keep Yeast Under Control
Your vagina, gut, and mouth all contain a mix of bacteria and fungi living in a carefully balanced ecosystem. In the vagina, Lactobacillus species dominate a healthy microbiome and act as a natural defense system. These bacteria compete with yeast for nutrients (especially glucose) and physical space on tissue surfaces. They also produce lactic acid that keeps the environment acidic, which suppresses yeast growth, and they release antimicrobial substances that directly inhibit other organisms.
This process is called colonization resistance. It works through two channels simultaneously: the bacteria compete directly with yeast for resources, and they also stimulate your immune system to stay alert against potential invaders. As long as this bacterial population stays strong, yeast organisms like Candida albicans remain in small, harmless numbers. You can carry Candida without ever having symptoms.
What Antibiotics Do to That Balance
Antibiotics can’t distinguish between the bacteria causing your infection and the beneficial bacteria protecting your body. When you take a broad-spectrum antibiotic for a sinus infection, urinary tract infection, or strep throat, the drug kills bacteria throughout your entire body. That includes the Lactobacillus populations in your vagina and the diverse bacterial communities in your gut.
Once those protective bacteria are depleted, several things change at once. The chemical environment shifts. Research in mice has shown that antibiotic treatment reduces levels of short-chain fatty acids (compounds normally produced by gut bacteria) while increasing available carbohydrates and sugars. This is essentially rolling out a red carpet for Candida: fewer competitors, more food, and a less hostile chemical environment.
With colonization resistance suppressed, Candida doesn’t just grow in larger numbers. It actually changes its behavior. The yeast shifts from a harmless round cell form to an invasive filamentous form that can penetrate tissue. It also begins forming biofilms, sticky clusters of cells that are harder for your immune system to clear. In animal studies, mice that normally resist Candida colonization become persistently colonized after antibiotic treatment.
Which Antibiotics Carry the Most Risk
Broad-spectrum antibiotics pose the greatest risk because they target the widest range of bacteria, causing the most collateral damage to your protective microbiome. The CDC lists high-dose, broad-spectrum, or long-term antibiotic use as a specific risk factor for candidiasis. Common culprits include amoxicillin (often prescribed for ear and sinus infections), tetracyclines, and cephalosporins.
Narrow-spectrum antibiotics, which target a smaller range of bacteria, are less likely to trigger a yeast infection because they leave more of your protective bacteria intact. Duration also matters. A longer course of antibiotics gives yeast more time to establish itself in the absence of bacterial competition. That said, even short courses carry meaningful risk, with the 22% incidence rate in the study mentioned above coming from standard short-course prescriptions.
Why Some People Are More Susceptible
Not everyone who takes antibiotics gets a yeast infection. In the same study, 37% of women in the antibiotic group had positive Candida cultures at follow-up, but only 22% developed actual symptoms. That gap highlights an important point: yeast can increase in number without necessarily causing problems. Whether you develop itching, discharge, and irritation depends on additional factors.
People who already carry higher baseline levels of Candida are more vulnerable, since less bacterial competition is needed before yeast reaches symptomatic levels. Hormonal factors matter too. Estrogen promotes the growth of both Lactobacillus and Candida, which is why yeast infections are more common during reproductive years and pregnancy. Other medications can compound the risk: corticosteroids suppress immune function, and hormonal contraceptives can alter the vaginal environment. Having diabetes or an otherwise weakened immune system also lowers the threshold for yeast overgrowth.
Reducing Your Risk During Antibiotic Treatment
If you’ve had antibiotic-associated yeast infections before, you’re likely to get them again with future antibiotic courses. Some practical steps can help. Probiotic supplements or foods containing live Lactobacillus cultures may help replenish protective bacteria during and after antibiotic treatment, though evidence on their effectiveness for preventing vaginal yeast infections specifically is mixed. Wearing breathable cotton underwear, avoiding douching, and reducing sugar intake can also create a less favorable environment for yeast overgrowth.
If you know you’re prone to yeast infections after antibiotics, talk to your prescriber before starting your course. In some cases, a single dose of antifungal medication taken alongside or shortly after the antibiotic can prevent yeast overgrowth before symptoms start. The key is that your body will rebuild its bacterial populations naturally after you finish antibiotics, but the window of vulnerability can last several weeks while that recovery happens.